Home » Newsletters » BioWorld

BioWorld

Aug. 2, 1993

View Archived Issues

SKB TO MARKET THERATECH'S TESTOSTERONE PATCH

REGENERON FILES FOR OFFERING

APPOINTMENTS AND ADVANCEMENTS

TELOR BEGINS PHASE II TRIALS

NEW WAY TO INHIBIT GENE EXPRESSION

HOUSTON BIOTECH DEBUTS WITH $3.3 MILLION IPO

ORPHAN DRUG TAX CREDIT REVIVED

CYGNUS FILES IND FOR MULTIPLE-DOSE PATCHES

LIFECORE ACQUIRES DENTAL IMPLANT COMPANY

BIOMATRIX LICENSES EYE FLUID IN CANADA

AFFYMAX, ALZA FORMALIZE DEVELOPMENT PROGRAM

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 21, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
New biomarker may improve RSV drug screening
BioWorld
Respiratory syncytial virus (RSV) infection is responsible for 3.2 million hospital admissions and about 118,000 deaths in children under 5 years of age. The...